Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hochuekkito for pre-frailty and frailty in hemodialysis patients
jRCT1071260104Recruiting
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of buzhong yiqi in Fragility. Primary endpoint: Change in apathy score from baseline to week 12. Started Oct 2026; status: recruiting.
02
Drugs
buzhong yiqi
03
Conditions
Fragility
Beyond the preview
Go deeper on jRCT1071260104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071260104.